Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Prediagnostic use of hormone therapy and mortality after breast cancer.

Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM, Stampfer MJ, Willett WC.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):864-71. doi: 10.1158/1055-9965.EPI-07-0610. Epub 2008 Apr 1. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1943.

2.

Estrogen replacement therapy and breast cancer survival in a large screening study.

Schairer C, Gail M, Byrne C, Rosenberg PS, Sturgeon SR, Brinton LA, Hoover RN.

J Natl Cancer Inst. 1999 Feb 3;91(3):264-70.

PMID:
10037105
3.

Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.

Thorbjarnardottir T, Olafsdottir EJ, Valdimarsdottir UA, Olafsson O, Tryggvadottir L.

Acta Oncol. 2014 Jun;53(6):752-8. doi: 10.3109/0284186X.2013.878471. Epub 2014 Jan 24.

PMID:
24460068
4.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.

5.

Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT)

Sourander L, Rajala T, Räihä I, Mäkinen J, Erkkola R, Helenius H.

Lancet. 1998 Dec 19-26;352(9145):1965-9. Erratum in: Lancet 1999 Jan 23;353(9149):330.

PMID:
9872245
6.

Hormone therapy in relation to survival from large bowel cancer.

Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Trentham Dietz A.

Cancer Causes Control. 2009 May;20(4):409-16. doi: 10.1007/s10552-008-9255-1. Epub 2008 Nov 9.

7.

Breast cancer and hormone-replacement therapy in the Million Women Study.

Beral V; Million Women Study Collaborators..

Lancet. 2003 Aug 9;362(9382):419-27. Erratum in: Lancet. 2003 Oct 4;362(9390):1160.

PMID:
12927427
8.

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.

O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS.

J Natl Cancer Inst. 2001 May 16;93(10):754-62.

PMID:
11353785
9.

Breast cancer risk with postmenopausal hormonal treatment.

Collins JA, Blake JM, Crosignani PG.

Hum Reprod Update. 2005 Nov-Dec;11(6):545-60. Epub 2005 Sep 8. Review. Erratum in: Hum Reprod Update. 2006 May-Jun;12(3):331.

PMID:
16150813
10.
11.

Hormone replacement therapy and the risk of death from breast cancer: a systematic review.

Nanda K, Bastian LA, Schulz K.

Am J Obstet Gynecol. 2002 Feb;186(2):325-34.

PMID:
11854659
12.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.

Obi N, Heinz J, Seibold P, Vrieling A, Rudolph A, Chang-Claude J, Berger J, Flesch-Janys D.

Int J Cancer. 2016 May 1;138(9):2098-108. doi: 10.1002/ijc.29951. Epub 2015 Dec 30.

13.

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.

Rosenberg LU, Granath F, Dickman PW, Einarsdóttir K, Wedrén S, Persson I, Hall P.

Breast Cancer Res. 2008;10(5):R78. doi: 10.1186/bcr2145. Epub 2008 Sep 19.

14.

Postmenopausal estrogen and progestin use in relation to breast cancer risk.

Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):593-600.

15.

Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.

Yuen J, Persson I, Bergkvist L, Hoover R, Schairer C, Adami HO.

Cancer Causes Control. 1993 Jul;4(4):369-74.

PMID:
8394149
16.

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.

Beral V, Reeves G, Bull D, Green J; Million Women Study Collaborators..

J Natl Cancer Inst. 2011 Feb 16;103(4):296-305. doi: 10.1093/jnci/djq527. Epub 2011 Jan 28.

17.

The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.

Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom AR.

Ann Intern Med. 1997 Dec 1;127(11):973-80.

PMID:
9412302
18.

Estrogen replacement therapy in patients with early breast cancer.

Natrajan PK, Gambrell RD Jr.

Am J Obstet Gynecol. 2002 Aug;187(2):289-94; discussion 294-5.

PMID:
12193914
19.

Postmenopausal hormone therapy and mortality.

Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH, Speizer FE.

N Engl J Med. 1997 Jun 19;336(25):1769-75.

20.

Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort.

Marshall SF, Clarke CA, Deapen D, Henderson K, Largent J, Neuhausen SL, Reynolds P, Ursin G, Horn-Ross PL, Stram DO, Templeman C, Bernstein L.

Breast Cancer Res. 2010;12(1):R4. doi: 10.1186/bcr2467. Epub 2010 Jan 8.

Supplemental Content

Support Center